A battle for kids' pollen proclivities is shaping up this allergy season. Both Sanofi's ($SNY) Nasacort and GlaxoSmithKline's ($GSK) Flonase have introduced children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback